Cargando…
A synthetic peptide as an allosteric inhibitor of human arginase I and II
Arginine metabolism mediated by arginases plays a critical role in cell and tissue function. The arginine hydrolysis is deeply involved in the urea cycle, which helps the kidney excrete ammonia from blood. Upregulation of arginases affects microenvironment stability due to the presence of excess ure...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7925462/ https://www.ncbi.nlm.nih.gov/pubmed/33590412 http://dx.doi.org/10.1007/s11033-021-06176-5 |
_version_ | 1783659272738963456 |
---|---|
author | Gao, Kai Lunev, Sergey van den Berg, Mariska P. M. Al-Dahmani, Zayana M. Evans, Stephen Mertens, Dyon A. L. J. Meurs, Herman Gosens, Reinoud Groves, Matthew R. |
author_facet | Gao, Kai Lunev, Sergey van den Berg, Mariska P. M. Al-Dahmani, Zayana M. Evans, Stephen Mertens, Dyon A. L. J. Meurs, Herman Gosens, Reinoud Groves, Matthew R. |
author_sort | Gao, Kai |
collection | PubMed |
description | Arginine metabolism mediated by arginases plays a critical role in cell and tissue function. The arginine hydrolysis is deeply involved in the urea cycle, which helps the kidney excrete ammonia from blood. Upregulation of arginases affects microenvironment stability due to the presence of excess urea in blood. To regulate the arginase activities properly, a synthetic peptide based on the structure of human arginase I was designed and assessed. Preliminary data shows it inhibits human arginase I and II with an IC(50) of 2.4 ± 0.3 and 1.8 ± 0.1 mmol, respectively. Our kinetic analysis indicates the inhibition is not competitive with substrate – suggesting an allosteric mechanism. This result provides a step towards specific inhibitors design. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s11033-021-06176-5. |
format | Online Article Text |
id | pubmed-7925462 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Springer Netherlands |
record_format | MEDLINE/PubMed |
spelling | pubmed-79254622021-03-19 A synthetic peptide as an allosteric inhibitor of human arginase I and II Gao, Kai Lunev, Sergey van den Berg, Mariska P. M. Al-Dahmani, Zayana M. Evans, Stephen Mertens, Dyon A. L. J. Meurs, Herman Gosens, Reinoud Groves, Matthew R. Mol Biol Rep Short Communication Arginine metabolism mediated by arginases plays a critical role in cell and tissue function. The arginine hydrolysis is deeply involved in the urea cycle, which helps the kidney excrete ammonia from blood. Upregulation of arginases affects microenvironment stability due to the presence of excess urea in blood. To regulate the arginase activities properly, a synthetic peptide based on the structure of human arginase I was designed and assessed. Preliminary data shows it inhibits human arginase I and II with an IC(50) of 2.4 ± 0.3 and 1.8 ± 0.1 mmol, respectively. Our kinetic analysis indicates the inhibition is not competitive with substrate – suggesting an allosteric mechanism. This result provides a step towards specific inhibitors design. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s11033-021-06176-5. Springer Netherlands 2021-02-15 2021 /pmc/articles/PMC7925462/ /pubmed/33590412 http://dx.doi.org/10.1007/s11033-021-06176-5 Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Short Communication Gao, Kai Lunev, Sergey van den Berg, Mariska P. M. Al-Dahmani, Zayana M. Evans, Stephen Mertens, Dyon A. L. J. Meurs, Herman Gosens, Reinoud Groves, Matthew R. A synthetic peptide as an allosteric inhibitor of human arginase I and II |
title | A synthetic peptide as an allosteric inhibitor of human arginase I and II |
title_full | A synthetic peptide as an allosteric inhibitor of human arginase I and II |
title_fullStr | A synthetic peptide as an allosteric inhibitor of human arginase I and II |
title_full_unstemmed | A synthetic peptide as an allosteric inhibitor of human arginase I and II |
title_short | A synthetic peptide as an allosteric inhibitor of human arginase I and II |
title_sort | synthetic peptide as an allosteric inhibitor of human arginase i and ii |
topic | Short Communication |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7925462/ https://www.ncbi.nlm.nih.gov/pubmed/33590412 http://dx.doi.org/10.1007/s11033-021-06176-5 |
work_keys_str_mv | AT gaokai asyntheticpeptideasanallostericinhibitorofhumanarginaseiandii AT lunevsergey asyntheticpeptideasanallostericinhibitorofhumanarginaseiandii AT vandenbergmariskapm asyntheticpeptideasanallostericinhibitorofhumanarginaseiandii AT aldahmanizayanam asyntheticpeptideasanallostericinhibitorofhumanarginaseiandii AT evansstephen asyntheticpeptideasanallostericinhibitorofhumanarginaseiandii AT mertensdyonalj asyntheticpeptideasanallostericinhibitorofhumanarginaseiandii AT meursherman asyntheticpeptideasanallostericinhibitorofhumanarginaseiandii AT gosensreinoud asyntheticpeptideasanallostericinhibitorofhumanarginaseiandii AT grovesmatthewr asyntheticpeptideasanallostericinhibitorofhumanarginaseiandii AT gaokai syntheticpeptideasanallostericinhibitorofhumanarginaseiandii AT lunevsergey syntheticpeptideasanallostericinhibitorofhumanarginaseiandii AT vandenbergmariskapm syntheticpeptideasanallostericinhibitorofhumanarginaseiandii AT aldahmanizayanam syntheticpeptideasanallostericinhibitorofhumanarginaseiandii AT evansstephen syntheticpeptideasanallostericinhibitorofhumanarginaseiandii AT mertensdyonalj syntheticpeptideasanallostericinhibitorofhumanarginaseiandii AT meursherman syntheticpeptideasanallostericinhibitorofhumanarginaseiandii AT gosensreinoud syntheticpeptideasanallostericinhibitorofhumanarginaseiandii AT grovesmatthewr syntheticpeptideasanallostericinhibitorofhumanarginaseiandii |